Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinal Cone Photoreceptor Cells | 11 | 2020 | 27 | 4.640 |
Why?
|
| Retinitis Pigmentosa | 8 | 2022 | 27 | 3.050 |
Why?
|
| Retinal Rod Photoreceptor Cells | 9 | 2022 | 21 | 2.540 |
Why?
|
| Macular Degeneration | 5 | 2025 | 187 | 2.540 |
Why?
|
| TOR Serine-Threonine Kinases | 6 | 2016 | 121 | 1.900 |
Why?
|
| Retina | 10 | 2024 | 124 | 1.650 |
Why?
|
| Multiprotein Complexes | 4 | 2016 | 153 | 1.420 |
Why?
|
| Retinal Diseases | 2 | 2022 | 33 | 1.250 |
Why?
|
| Glycolysis | 3 | 2021 | 58 | 1.220 |
Why?
|
| Genetic Therapy | 8 | 2025 | 789 | 1.130 |
Why?
|
| Bruch Membrane | 2 | 2025 | 9 | 1.110 |
Why?
|
| Genetic Vectors | 6 | 2025 | 871 | 1.050 |
Why?
|
| Disease Models, Animal | 9 | 2022 | 2179 | 0.970 |
Why?
|
| Dependovirus | 6 | 2025 | 708 | 0.960 |
Why?
|
| Retinal Degeneration | 3 | 2017 | 27 | 0.880 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2025 | 35 | 0.880 |
Why?
|
| Animals | 36 | 2025 | 20613 | 0.870 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2025 | 94 | 0.870 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2021 | 77 | 0.850 |
Why?
|
| Mice | 26 | 2025 | 10816 | 0.810 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2021 | 212 | 0.800 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2022 | 4 | 0.790 |
Why?
|
| Retinal Dystrophies | 1 | 2022 | 4 | 0.790 |
Why?
|
| Eye Diseases | 2 | 2025 | 36 | 0.740 |
Why?
|
| Transduction, Genetic | 4 | 2024 | 237 | 0.730 |
Why?
|
| Retinal Vasculitis | 1 | 2021 | 7 | 0.720 |
Why?
|
| Choroidal Neovascularization | 1 | 2021 | 28 | 0.710 |
Why?
|
| Eye Proteins | 5 | 2015 | 74 | 0.700 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 6 | 2022 | 52 | 0.680 |
Why?
|
| Macula Lutea | 1 | 2020 | 22 | 0.670 |
Why?
|
| Gene Transfer Techniques | 4 | 2025 | 321 | 0.650 |
Why?
|
| Caspase 7 | 1 | 2017 | 18 | 0.560 |
Why?
|
| Vision, Ocular | 2 | 2015 | 20 | 0.560 |
Why?
|
| Blindness | 2 | 2022 | 41 | 0.560 |
Why?
|
| Mice, Knockout | 8 | 2025 | 2107 | 0.560 |
Why?
|
| Rod Cell Outer Segment | 1 | 2017 | 8 | 0.550 |
Why?
|
| Cell Survival | 6 | 2018 | 568 | 0.540 |
Why?
|
| Eye | 3 | 2008 | 54 | 0.520 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3387 | 0.520 |
Why?
|
| Geographic Atrophy | 1 | 2016 | 20 | 0.490 |
Why?
|
| Light Signal Transduction | 1 | 2015 | 6 | 0.480 |
Why?
|
| Thioredoxins | 1 | 2015 | 17 | 0.480 |
Why?
|
| Apoptosis | 2 | 2017 | 1073 | 0.460 |
Why?
|
| Aging | 1 | 2020 | 746 | 0.440 |
Why?
|
| Insulin | 3 | 2016 | 686 | 0.410 |
Why?
|
| Cell Death | 6 | 2018 | 284 | 0.410 |
Why?
|
| Electroretinography | 3 | 2017 | 26 | 0.390 |
Why?
|
| Plasmids | 1 | 2013 | 291 | 0.380 |
Why?
|
| Trans-Activators | 3 | 2019 | 313 | 0.370 |
Why?
|
| Color Vision | 1 | 2011 | 4 | 0.370 |
Why?
|
| Drosophila Proteins | 3 | 2008 | 692 | 0.330 |
Why?
|
| Hexokinase | 2 | 2021 | 11 | 0.330 |
Why?
|
| Oxidative Stress | 1 | 2011 | 297 | 0.320 |
Why?
|
| Intravitreal Injections | 2 | 2021 | 49 | 0.310 |
Why?
|
| Signal Transduction | 3 | 2019 | 3033 | 0.310 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2008 | 48 | 0.300 |
Why?
|
| Humans | 16 | 2025 | 63149 | 0.280 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 156 | 0.270 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2007 | 18 | 0.270 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2007 | 15 | 0.270 |
Why?
|
| Elastin | 1 | 2025 | 10 | 0.240 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2016 | 84 | 0.230 |
Why?
|
| Laminin | 1 | 2025 | 78 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 429 | 0.230 |
Why?
|
| Collagen | 1 | 2025 | 123 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 199 | 0.220 |
Why?
|
| Drosophila melanogaster | 2 | 2008 | 492 | 0.220 |
Why?
|
| DNA-Binding Proteins | 3 | 2008 | 1183 | 0.220 |
Why?
|
| Complement Factor H | 1 | 2025 | 118 | 0.220 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 1614 | 0.220 |
Why?
|
| Carrier Proteins | 1 | 2008 | 705 | 0.220 |
Why?
|
| Dysautonomia, Familial | 1 | 2023 | 1 | 0.220 |
Why?
|
| Capsid | 1 | 2024 | 96 | 0.210 |
Why?
|
| Biological Evolution | 1 | 2004 | 120 | 0.210 |
Why?
|
| Genes, Viral | 1 | 2022 | 57 | 0.200 |
Why?
|
| Electroporation | 3 | 2013 | 35 | 0.190 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2002 | 37 | 0.190 |
Why?
|
| Retinal Neurons | 2 | 2014 | 2 | 0.190 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 126 | 0.180 |
Why?
|
| Ubiquitin | 1 | 2022 | 98 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 296 | 0.180 |
Why?
|
| Neurodegenerative Diseases | 1 | 2023 | 143 | 0.180 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 28 | 0.180 |
Why?
|
| Dogs | 1 | 2022 | 325 | 0.180 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 302 | 0.180 |
Why?
|
| Proteolysis | 1 | 2022 | 145 | 0.170 |
Why?
|
| Lipofuscin | 1 | 2020 | 5 | 0.170 |
Why?
|
| Uveal Neoplasms | 1 | 2019 | 50 | 0.160 |
Why?
|
| Lipoproteins | 1 | 2020 | 83 | 0.160 |
Why?
|
| Genes, Reporter | 2 | 2017 | 255 | 0.160 |
Why?
|
| Cell Differentiation | 2 | 2017 | 1348 | 0.160 |
Why?
|
| Retinal Bipolar Cells | 2 | 2010 | 4 | 0.150 |
Why?
|
| Drosophila | 1 | 2002 | 434 | 0.150 |
Why?
|
| Aerobiosis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 2 | 2008 | 2 | 0.140 |
Why?
|
| Arrestins | 1 | 2017 | 6 | 0.140 |
Why?
|
| Microarray Analysis | 2 | 2008 | 64 | 0.140 |
Why?
|
| Injections, Intraocular | 1 | 2017 | 5 | 0.140 |
Why?
|
| Female | 4 | 2025 | 32709 | 0.140 |
Why?
|
| Male | 3 | 2025 | 29717 | 0.130 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 394 | 0.130 |
Why?
|
| Cricetulus | 1 | 2017 | 99 | 0.130 |
Why?
|
| CHO Cells | 1 | 2017 | 188 | 0.130 |
Why?
|
| Paired Box Transcription Factors | 2 | 2008 | 16 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2017 | 193 | 0.130 |
Why?
|
| Cytomegalovirus | 1 | 2017 | 91 | 0.130 |
Why?
|
| Blotting, Western | 1 | 2017 | 607 | 0.130 |
Why?
|
| Iodates | 1 | 2016 | 1 | 0.130 |
Why?
|
| Stress, Physiological | 1 | 2018 | 193 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2017 | 116 | 0.130 |
Why?
|
| Melanoma | 1 | 2019 | 331 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2019 | 1513 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 1 | 2017 | 364 | 0.120 |
Why?
|
| Viral Tropism | 1 | 2016 | 51 | 0.120 |
Why?
|
| Retinal Ganglion Cells | 2 | 2023 | 30 | 0.120 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2015 | 7 | 0.120 |
Why?
|
| Caspase 2 | 1 | 2015 | 7 | 0.120 |
Why?
|
| Capsid Proteins | 1 | 2016 | 98 | 0.120 |
Why?
|
| Enzyme Activation | 1 | 2016 | 380 | 0.120 |
Why?
|
| NADP | 1 | 2015 | 23 | 0.120 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2015 | 17 | 0.120 |
Why?
|
| Muscles | 1 | 2016 | 179 | 0.120 |
Why?
|
| Mitochondria | 1 | 2018 | 370 | 0.110 |
Why?
|
| Sirolimus | 1 | 2015 | 92 | 0.110 |
Why?
|
| Models, Neurological | 1 | 2015 | 80 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2016 | 268 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2015 | 171 | 0.110 |
Why?
|
| Inflammation | 1 | 2021 | 1144 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 674 | 0.110 |
Why?
|
| In Situ Hybridization | 3 | 2012 | 216 | 0.110 |
Why?
|
| Diabetic Retinopathy | 1 | 2015 | 53 | 0.110 |
Why?
|
| Central Nervous System | 1 | 2016 | 197 | 0.110 |
Why?
|
| Stem Cells | 2 | 2014 | 258 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1275 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2014 | 64 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2007 | 765 | 0.100 |
Why?
|
| Cellular Senescence | 1 | 2014 | 110 | 0.100 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 377 | 0.100 |
Why?
|
| Transgenes | 2 | 2016 | 187 | 0.100 |
Why?
|
| Child | 1 | 2022 | 4520 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 424 | 0.100 |
Why?
|
| TRPC Cation Channels | 1 | 2012 | 11 | 0.100 |
Why?
|
| Glucose | 1 | 2015 | 467 | 0.090 |
Why?
|
| Eye Abnormalities | 3 | 2008 | 21 | 0.090 |
Why?
|
| DNA Replication | 1 | 2014 | 234 | 0.090 |
Why?
|
| Calcium Channels | 1 | 2012 | 103 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 126 | 0.090 |
Why?
|
| Homeodomain Proteins | 2 | 2004 | 266 | 0.090 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2011 | 44 | 0.090 |
Why?
|
| Genetic Loci | 1 | 2011 | 115 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2012 | 268 | 0.090 |
Why?
|
| TRPM Cation Channels | 1 | 2010 | 15 | 0.080 |
Why?
|
| Histones | 1 | 2014 | 483 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 5429 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 542 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 878 | 0.080 |
Why?
|
| Nutrition Disorders | 1 | 2008 | 7 | 0.080 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 2008 | 4 | 0.080 |
Why?
|
| Rhodopsin | 1 | 2008 | 14 | 0.080 |
Why?
|
| Antennapedia Homeodomain Protein | 1 | 2008 | 2 | 0.080 |
Why?
|
| Calcium | 1 | 2012 | 573 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 240 | 0.070 |
Why?
|
| Injections | 1 | 2008 | 81 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 189 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2008 | 127 | 0.070 |
Why?
|
| Mice, Inbred DBA | 3 | 2012 | 84 | 0.070 |
Why?
|
| Amacrine Cells | 1 | 2007 | 1 | 0.070 |
Why?
|
| Retinal Horizontal Cells | 1 | 2007 | 2 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 47 | 0.070 |
Why?
|
| Cell Count | 1 | 2007 | 130 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 640 | 0.060 |
Why?
|
| Autophagy | 1 | 2008 | 225 | 0.060 |
Why?
|
| Ultrasonography | 1 | 2008 | 481 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 413 | 0.060 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 289 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 433 | 0.060 |
Why?
|
| PAX6 Transcription Factor | 1 | 2004 | 4 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2004 | 34 | 0.060 |
Why?
|
| Time Factors | 2 | 2008 | 3754 | 0.050 |
Why?
|
| Aged | 1 | 2020 | 14333 | 0.050 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2023 | 12 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 780 | 0.050 |
Why?
|
| Disease Progression | 2 | 2019 | 1166 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2024 | 136 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 670 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2023 | 162 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2025 | 452 | 0.050 |
Why?
|
| Ubiquitinated Proteins | 1 | 2022 | 1 | 0.050 |
Why?
|
| Protein Binding | 2 | 2008 | 1600 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2004 | 347 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 319 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1536 | 0.050 |
Why?
|
| Morphogenesis | 1 | 2002 | 112 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2002 | 107 | 0.040 |
Why?
|
| Microglia | 1 | 2024 | 242 | 0.040 |
Why?
|
| Gene Editing | 1 | 2025 | 316 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2019 | 980 | 0.040 |
Why?
|
| Binding Sites | 1 | 2002 | 902 | 0.040 |
Why?
|
| Base Sequence | 1 | 2002 | 1329 | 0.040 |
Why?
|
| Melanocytes | 1 | 2019 | 76 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2019 | 217 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1989 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2019 | 618 | 0.030 |
Why?
|
| Mutation | 2 | 2019 | 2604 | 0.030 |
Why?
|
| Phenotype | 2 | 2011 | 1199 | 0.030 |
Why?
|
| Food | 1 | 2016 | 77 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1461 | 0.030 |
Why?
|
| Kinetics | 1 | 2016 | 760 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cyclin E | 1 | 2014 | 14 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2016 | 379 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 197 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 777 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 837 | 0.020 |
Why?
|
| Oligodendrocyte Transcription Factor 2 | 1 | 2012 | 2 | 0.020 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2012 | 39 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1146 | 0.020 |
Why?
|
| Tonometry, Ocular | 1 | 2011 | 20 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2011 | 35 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2011 | 42 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 40 | 0.020 |
Why?
|
| Light | 1 | 2012 | 202 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2012 | 150 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 373 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 892 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 370 | 0.020 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2008 | 14 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 881 | 0.020 |
Why?
|
| Extremities | 1 | 2008 | 44 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2008 | 236 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2008 | 135 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2007 | 98 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2036 | 0.020 |
Why?
|
| Mitosis | 1 | 2008 | 214 | 0.020 |
Why?
|
| Gene Library | 1 | 2007 | 102 | 0.020 |
Why?
|
| DNA Probes | 1 | 2006 | 34 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 608 | 0.020 |
Why?
|
| DNA | 1 | 2008 | 830 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1176 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1645 | 0.010 |
Why?
|